GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Belluscura PLC (FRA:9VQ) » Definitions » Market Cap

Belluscura (FRA:9VQ) Market Cap : €28.62 Mil (As of May. 30, 2024)


View and export this data going back to 2021. Start your Free Trial

What is Belluscura Market Cap?

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Belluscura's share price for the quarter that ended in Jun. 2023 was €0.368. Belluscura's Shares Outstanding (EOP) for the quarter that ended in Jun. 2023 was 135.67 Mil. Therefore, Belluscura's market cap for the quarter that ended in Jun. 2023 was €49.93 Mil.

Belluscura's quarterly market cap declined from Jun. 2022 (€113.95 Mil) to Dec. 2022 (€90.42 Mil) and declined from Dec. 2022 (€90.42 Mil) to Jun. 2023 (€49.93 Mil).

Belluscura's annual market cap increased from Dec. 2020 (€0.00 Mil) to Dec. 2021 (€143.43 Mil) but then declined from Dec. 2021 (€143.43 Mil) to Dec. 2022 (€90.42 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Belluscura's Enterprise Value for Today is €27.04 Mil.


Belluscura Market Cap Historical Data

The historical data trend for Belluscura's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Belluscura Market Cap Chart

Belluscura Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22
Market Cap
- - - 143.43 90.42

Belluscura Semi-Annual Data
Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23
Market Cap Get a 7-Day Free Trial Premium Member Only 73.65 143.43 113.95 90.42 49.93

Competitive Comparison of Belluscura's Market Cap

For the Medical Devices subindustry, Belluscura's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Belluscura's Market Cap Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Belluscura's Market Cap distribution charts can be found below:

* The bar in red indicates where Belluscura's Market Cap falls into.



Belluscura Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

Belluscura's Market Cap for the fiscal year that ended in Dec. 2022 is calculated as

Market Cap (A: Dec. 2022 )=Share Price (A: Dec. 2022 )*Shares Outstanding (EOP) (A: Dec. 2022 )
=€0.735*123.017
=€90.42

Belluscura's Market Cap for the quarter that ended in Jun. 2023 is calculated as

Market Cap (Q: Jun. 2023 )=Share Price (Q: Jun. 2023 )*Shares Outstanding (EOP) (Q: Jun. 2023 )
=€0.368*135.67
=€49.93

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Belluscura  (FRA:9VQ) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the company’s debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.


Belluscura Market Cap Related Terms

Thank you for viewing the detailed overview of Belluscura's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.


Belluscura (FRA:9VQ) Business Description

Traded in Other Exchanges
Address
15 Fetter Lane, Holborn, London, GBR, EC4A 1BW
Belluscura PLC is a medical device company. Its first product, the X-PLOR, is a lightweight FDA-cleared portable oxygen concentrator designed to replace larger, metal oxygen tanks and heavier portable oxygen concentrator devices. The X-PLO2R weighs less than 1.5kg (3.25 lbs) and it is the first modular portable oxygen concentrator it will generate more oxygen by weight than any other FDA-cleared POC in its class. It either owns or exclusively licenses a total of 26 patents and applications relating to oxygen enrichment devices and treatments.

Belluscura (FRA:9VQ) Headlines

No Headlines